Skip to main content
TipRanks
Go Ultimate75% OFF

Alan Crane Insider Profile

4 Followers

Alan Crane, Director, Ten Percent Owner at Daré Bioscience, holds 0.00 shares in Pandion Therapeutics (Ticker: PAND), holds 30.00K shares in T2 Biosystems (Ticker: TTOO), holds 4.77M shares in Daré Bioscience (Ticker: DARE).

Alan Crane's Trading History

PAND
Pandion Therapeutics
Apr 01, 2021―Uninformative Sell217.31M$0.00
TTOO
T2 Biosystems
Aug 14, 2014DirectorInformative Buy330.00K$300.00
DARE
Daré Bioscience
Apr 15, 2014Director, Ten Percent OwnerUninformative Buy4.88M$3.14M
MNTA
Momenta Pharma
Apr 16, 2010―Informative Buy146.96K$32.21M

You May Also Like

Alan Crane insider profile FAQ

What is the percentage of profitable transactions made by Alan Crane?
The percentage of profitable transactions made by Alan Crane is 0%.
What is the average return per transaction made by Alan Crane?
The average return per transaction made by Alan Crane is -10.10%.
What stocks does Alan Crane hold?
Alan Crane holds: DARE, PAND, MNTA, TTOO stocks.
What was Alan Crane’s latest transaction?
Alan Crane’s latest transaction was an Uninformative Sell of $217.31M.
What was Alan Crane's most profitable transaction?
Alan Crane’s most profitable transaction was an Informative Buy of DARE stock on April 15, 2014. The return on the trade was -1.80%.
What is Alan Crane's role in Daré Bioscience?
Alan Crane's role in Daré Bioscience is Director, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.